Is Wegovy a GLP-1? What You Need to Know About This Weight Loss Medication

Last reviewed: June 10, 2026

Last updated: June 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Yes, Wegovy is a GLP-1 receptor agonist—a medication that mimics glucagon-like peptide-1, a hormone that regulates blood sugar and appetite. Approved by the FDA in 2021 for chronic weight management, Wegovy has helped millions of people lose weight by reducing hunger and food cravings. However, brand-name Wegovy costs $1,300+ monthly, making compounded semaglutide a practical alternative for accessible, personalized weight loss therapy.

What Does GLP-1 Mean in Weight Loss Treatment?

GLP-1 stands for glucagon-like peptide-1, a natural hormone your intestines release when you eat. This hormone tells your brain you're satisfied, slows stomach emptying, and helps control blood sugar levels. GLP-1 receptor agonists like Wegovy activate these same pathways in your body, creating a powerful appetite-suppressing effect that lasts hours after injection.

When you take a GLP-1 medication, you experience reduced hunger signals and increased feelings of fullness on smaller portions. Clinical trials show patients using GLP-1 agonists lose 15–22% of body weight over 68 weeks, compared to 2–3% with diet and exercise alone. This mechanism explains why GLP-1 therapy has become one of the most effective weight loss options available today.

How Semaglutide and Tirzepatide Compare as GLP-1 Options

Semaglutide, the active ingredient in Wegovy and Ozempic, is a GLP-1 receptor agonist that works by activating GLP-1 receptors throughout your body. Tirzepatide, available as Zepbound and Mounjaro, is a dual receptor agonist that activates both GLP-1 and GIP receptors, offering potentially greater weight loss in some patients. PlexusDx offers both as compounded injections, allowing your doctor to choose the option best suited to your genetic makeup and weight loss goals.

Compounded semaglutide injections at PlexusDx start at $149 monthly, while compounded tirzepatide injections begin at $249 monthly. Both medications come from licensed 503A compounding pharmacies and are available nationwide without insurance. The Precision Peptide Genetic Test ($99 add-on after your first month) can identify which GLP-1 or dual-receptor pathway your body responds to most effectively, helping personalize your treatment.

Why Compounded GLP-1 Medications Cost Less Than Brand Names

Wegovy's brand-name price reflects years of clinical trials, FDA approval processes, and marketing costs that manufacturers recoup through premium pricing. Compounded semaglutide contains the same active pharmaceutical ingredient but is prepared by licensed 503A compounding pharmacies, eliminating unnecessary markups while maintaining the same quality standards. PlexusDx partners with these pharmacies to deliver compounded medications at a fraction of brand-name costs.

Insurance often doesn't cover Wegovy unless you meet specific criteria, leaving many patients to pay full price or go without treatment. PlexusDx requires no insurance and no membership fees—compounded semaglutide starts at $149 monthly and is HSA/FSA eligible. This direct-to-patient model removes intermediaries, allowing you to access medically supervised GLP-1 therapy affordably from home.

Genetic Testing to Optimize Your GLP-1 Therapy Response

Not everyone responds identically to GLP-1 medications because genetic variations influence how your body processes these compounds and responds to appetite regulation. PlexusDx's Precision Peptide Genetic Test examines 14 distinct pathways involving 49 peptides and 150+ genetic insights, including key variants like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These genetic markers predict which GLP-1 or dual-receptor approach your body is most likely to benefit from.

By understanding your genetic blueprint before starting treatment, your PlexusDx physician can recommend semaglutide, tirzepatide, or the dual-compound GLP-Squared injection tailored to your peptide pathways. This precision approach increases treatment success and reduces trial-and-error medication changes. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment, offering personalization that brand-name weight loss clinics rarely provide.

Side Effects and Safety of GLP-1 Receptor Agonists

GLP-1 medications are generally well-tolerated, though common side effects include mild nausea, vomiting, constipation, and occasional diarrhea—most often at the start of treatment. These effects typically decrease over time as your body adjusts, especially when your dose is increased gradually under medical supervision. Serious side effects are rare but may include pancreatitis, gallbladder problems, or thyroid concerns; patients with a personal or family history of medullary thyroid cancer should not use GLP-1 agonists.

PlexusDx physicians monitor your progress and side effects through regular check-ins, adjusting your treatment plan as needed. Because compounded medications are prepared individually at licensed 503A pharmacies, your pharmacy can accommodate dosage adjustments smoothly without supply interruptions. Staying hydrated, eating small frequent meals, and starting at lower doses minimize side effects while allowing your body to benefit from appetite regulation and weight loss.

Accessing Compounded Semaglutide Without Insurance Barriers

One major barrier to GLP-1 therapy is insurance coverage denial—many plans refuse to cover Wegovy unless you have type 2 diabetes or meet restrictive BMI criteria. PlexusDx removes this obstacle by offering direct access to compounded semaglutide injections at $149 monthly, no insurance required and no membership fees. Patients nationwide can begin treatment immediately through a simple online consultation with a licensed physician.

Your PlexusDx membership includes doctor oversight, dose adjustments, prescription refills, and access to the Precision Peptide Genetic Test. HSA and FSA accounts cover compounded GLP-1 medications, allowing you to use pre-tax health dollars for treatment. If brand-name Wegovy costs you $1,300+ monthly, compounded semaglutide at $149 monthly removes financial obstacles while delivering the same active ingredient in a medically supervised program.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Wegovy the only GLP-1 medication available for weight loss?

No. Semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) are the two main GLP-1 and dual-receptor options FDA-approved for weight management. PlexusDx offers compounded versions of both medications starting at $149 and $249 monthly respectively, plus GLP-Squared, a dual-compound injection combining semaglutide and tirzepatide for patients seeking maximum benefit from both pathways.

How much weight can I expect to lose with GLP-1 therapy?

Clinical trials show average weight loss of 15–22% of body weight over 68 weeks with GLP-1 agonists, though individual results vary based on genetics, lifestyle, and adherence. PlexusDx's Precision Peptide Genetic Test helps predict your likely response by analyzing genetic variants controlling appetite, metabolism, and fat storage, allowing personalized treatment selection for optimal outcomes.

Why is PlexusDx semaglutide so much cheaper than Wegovy?

PlexusDx compounded semaglutide ($149/mo) is prepared by licensed 503A pharmacies using the same active ingredient as brand-name Wegovy ($1,300+/mo), but without the costs of brand development, clinical trials, and direct-to-consumer marketing. Direct-to-patient delivery and elimination of insurance intermediaries further reduce costs while maintaining quality and medical supervision.

Are compounded medications as safe as FDA-approved brand names?

Compounded semaglutide and tirzepatide from licensed 503A pharmacies contain identical active ingredients to FDA-approved medications and undergo the same quality testing. The difference is that compounding allows individualized preparation and dosing. PlexusDx patients receive physician-supervised care, regular monitoring, and dose adjustments just as brand-name users do, ensuring safety and effectiveness.

Can the Precision Peptide Genetic Test tell me which GLP-1 medication is best for me?

Yes. The Precision Peptide Genetic Test analyzes 14 pathways and 150+ genetic insights including GLP1R, GIPR, FTO, and MC4R variants that predict your appetite regulation and weight loss potential with different medications. Your PlexusDx physician uses these results to recommend semaglutide, tirzepatide, or GLP-Squared tailored to your genetic blueprint, increasing success rates and reducing trial-and-error treatment changes.

Related Reading

• Glp 1 For Weight Loss 2
• Glp 1 Weight Loss Before And After
• Glp 1 Dosage For Weight Loss
• Glp 1 Receptor Agonist For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.